Passage Bio Inc.
2005 Market Street Floor 39th, 19103-7026, United States
About the sponsor
Clinical research activity is centered on frontotemporal dementia (FTD), with attention to inherited forms linked to GRN and C9orf72 mutations. The sponsor’s work in this area reflects interest in neurodegenerative conditions that affect behavior, language, and executive function.
- Neurodegeneration
- Genetic dementia
- GRN-associated disease
- C9orf72-related disease
The research landscape is focused on clinically relevant aspects of FTD and its molecular subtypes, supporting therapeutic development in a rare central nervous system disorder.
Try clearing a filter, or search the whole catalogue.
Are you running a clinical trial?
Increase visibility for your trials and help patients find your site through our platform.
